Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 14 | 55136284 | intron variant | T/G | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
14 | 55136343 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
14 | 55145762 | downstream gene variant | C/T | snv | 5.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
14 | 55142516 | intron variant | C/T | snv | 0.57 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
14 | 55143056 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
14 | 55143237 | intron variant | C/A | snv | 0.36 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
14 | 55126454 | intron variant | A/C | snv | 0.36 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.752 | 0.200 | 14 | 55138318 | missense variant | A/C | snv | 4.1E-06; 0.45 | 0.57 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
14 | 55134221 | intron variant | G/A | snv | 5.7E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
14 | 55140648 | intron variant | C/T | snv | 0.57 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
14 | 55144222 | intron variant | C/G | snv | 0.42 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.040 | 14 | 55136284 | intron variant | T/G | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 14 | 55145121 | missense variant | A/T | snv | 6.5E-02 | 5.7E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.120 | 14 | 55145121 | missense variant | A/T | snv | 6.5E-02 | 5.7E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.120 | 14 | 55145121 | missense variant | A/T | snv | 6.5E-02 | 5.7E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.120 | 14 | 55145121 | missense variant | A/T | snv | 6.5E-02 | 5.7E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.120 | 14 | 55145121 | missense variant | A/T | snv | 6.5E-02 | 5.7E-02 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.320 | 14 | 55138217 | missense variant | C/A;G | snv | 0.35 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 |